MIRA Pharmaceuticals, Enterprise Value Over Time
| MIRA Stock | 1.29 0.02 1.57% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out MIRA Pharmaceuticals, Performance and MIRA Pharmaceuticals, Correlation. MIRA |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MIRA Pharmaceuticals,. If investors know MIRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MIRA Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Return On Assets (1.78) | Return On Equity (7.49) |
The market value of MIRA Pharmaceuticals, is measured differently than its book value, which is the value of MIRA that is recorded on the company's balance sheet. Investors also form their own opinion of MIRA Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is MIRA Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MIRA Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect MIRA Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MIRA Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if MIRA Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MIRA Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Enterprise Value Analysis
Compare MIRA Pharmaceuticals, and related stocks such as World Houseware, CapitaLand Investment, and Western Asset Investment Enterprise Value Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IGI | 235.5 M | 235.5 M | 235.5 M | 235.5 M | 235.5 M | 235.5 M | 235.5 M | 193.9 M | 230.2 M | 232.2 M | 238.9 M | 178.7 M | 177.3 M | 203.8 M | 233.6 M |
| CHD | 240.6 M | 574.2 M | 574.2 M | 574.2 M | 574.2 M | 574.2 M | 574.2 M | 574.2 M | 574.2 M | 574.2 M | 574.2 M | 574.2 M | 574.2 M | 516.8 M | 332.4 M |
| WEYS | 80 M | 366.4 M | 366.4 M | 366.4 M | 366.4 M | 366.4 M | 366.4 M | 366.4 M | 366.4 M | 366.4 M | 366.4 M | 366.4 M | 366.4 M | 329.8 M | 346.3 M |
| BKH | 461.3 M | 4 B | 4 B | 4 B | 4 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 3.9 B | 3.5 B | 3.7 B |
MIRA Pharmaceuticals, and related stocks such as World Houseware, CapitaLand Investment, and Western Asset Investment Enterprise Value description
Enterprise Value (or EV) is usually referred to as MIRA Pharmaceuticals, theoretical takeover price. In the event of an acquisition, an acquirer would have to take on MIRA Pharmaceuticals, debt, but would also pocket its cash. Enterprise Value is more accurate representation of MIRA Pharmaceuticals, value than its market capitalization because it takes into account all of MIRA Pharmaceuticals, Common existing debt. A measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization that includes the market capitalization, plus total debt, minority interest and preferred shares, minus total cash and cash equivalents.My Equities
My Current Equities and Potential Positions
| MIRA Pharmaceuticals, Common | MIRA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Maryland; U.S.A |
| Exchange | NASDAQ Exchange |
null 1.29
Check out MIRA Pharmaceuticals, Performance and MIRA Pharmaceuticals, Correlation. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
MIRA Pharmaceuticals, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.